JP2005530852A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530852A5
JP2005530852A5 JP2004517277A JP2004517277A JP2005530852A5 JP 2005530852 A5 JP2005530852 A5 JP 2005530852A5 JP 2004517277 A JP2004517277 A JP 2004517277A JP 2004517277 A JP2004517277 A JP 2004517277A JP 2005530852 A5 JP2005530852 A5 JP 2005530852A5
Authority
JP
Japan
Prior art keywords
hydrogen
lower alkyl
biphenyl
amino
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004517277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530852A (ja
JP3852708B2 (ja
Filing date
Publication date
Priority claimed from AUPS3241A external-priority patent/AUPS324102A0/en
Priority claimed from AU2002953604A external-priority patent/AU2002953604A0/en
Application filed filed Critical
Priority claimed from PCT/JP2003/008061 external-priority patent/WO2004002939A2/en
Publication of JP2005530852A publication Critical patent/JP2005530852A/ja
Publication of JP2005530852A5 publication Critical patent/JP2005530852A5/ja
Application granted granted Critical
Publication of JP3852708B2 publication Critical patent/JP3852708B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004517277A 2002-06-27 2003-06-25 アミノアルコール誘導体 Expired - Fee Related JP3852708B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS3241A AUPS324102A0 (en) 2002-06-27 2002-06-27 Aminoalcohol derivatives
AU2002953604A AU2002953604A0 (en) 2002-12-30 2002-12-30 Aminoalcohol derivatives
PCT/JP2003/008061 WO2004002939A2 (en) 2002-06-27 2003-06-25 Aminoalcohol derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006195098A Division JP4587127B2 (ja) 2002-06-27 2006-07-18 アミノアルコール誘導体

Publications (3)

Publication Number Publication Date
JP2005530852A JP2005530852A (ja) 2005-10-13
JP2005530852A5 true JP2005530852A5 (enExample) 2006-04-13
JP3852708B2 JP3852708B2 (ja) 2006-12-06

Family

ID=30001235

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004517277A Expired - Fee Related JP3852708B2 (ja) 2002-06-27 2003-06-25 アミノアルコール誘導体
JP2006195098A Expired - Fee Related JP4587127B2 (ja) 2002-06-27 2006-07-18 アミノアルコール誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006195098A Expired - Fee Related JP4587127B2 (ja) 2002-06-27 2006-07-18 アミノアルコール誘導体

Country Status (14)

Country Link
US (2) US7037938B2 (enExample)
EP (1) EP1546086A2 (enExample)
JP (2) JP3852708B2 (enExample)
KR (1) KR100693367B1 (enExample)
AR (1) AR040473A1 (enExample)
BR (1) BR0311788A (enExample)
CA (1) CA2492065A1 (enExample)
MX (1) MXPA04012783A (enExample)
NO (1) NO20050470L (enExample)
NZ (1) NZ537206A (enExample)
PL (1) PL375195A1 (enExample)
RU (1) RU2319698C2 (enExample)
TW (1) TWI331137B (enExample)
WO (1) WO2004002939A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4618250B2 (ja) * 2003-12-23 2011-01-26 アステラス製薬株式会社 アミノアルコール誘導体
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
EP1778638A1 (en) 2004-07-21 2007-05-02 Theravance, Inc. Diaryl ether beta2 adrenergic receptor agonists
EP1786762A2 (en) * 2004-09-10 2007-05-23 Theravance, Inc. Amidine substituted aryl aniline compounds
KR101052462B1 (ko) 2004-09-21 2011-07-28 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체
AU2005285812B2 (en) * 2004-09-21 2011-02-24 Astellas Pharma Inc. Aminoalcohol derivatives
FR2880885B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'acide phenylbenzoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
ES2328616T3 (es) * 2006-04-21 2009-11-16 Cellzome Limited Acidos bifenil carboxilicos sustituidos y sus derivados.
WO2008005338A1 (en) * 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
ES2302447B1 (es) * 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
JP2011516482A (ja) * 2008-04-04 2011-05-26 メルク・シャープ・エンド・ドーム・コーポレイション β3アドレナリン作動性受容体アゴニストとしてのヒドロキシメチルピロリジン
CA2721060A1 (en) * 2008-04-09 2009-10-15 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8541581B2 (en) 2009-04-07 2013-09-24 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8546564B2 (en) 2009-04-07 2013-10-01 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
JP2013518886A (ja) * 2010-02-03 2013-05-23 インフイニトイ プハルマセウトイカルス インコーポレイテッド 脂肪酸アミドヒドロラーゼ阻害剤
FR2961204A1 (fr) * 2010-06-11 2011-12-16 Centre Nat Rech Scient Procede de substitution nucleophile aromatique a partir d'acides difluorobenzoiques
CN103119034B (zh) 2010-04-16 2016-08-03 拜耳知识产权有限责任公司 作为害虫防治剂的杂环化合物
WO2012000896A2 (de) 2010-06-28 2012-01-05 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
US11078528B2 (en) 2015-10-12 2021-08-03 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
WO2017157735A1 (de) 2016-03-15 2017-09-21 Bayer Cropscience Aktiengesellschaft Substituierte sulfonylamide zur bekämpfung tierischer schädlinge
TW201822637A (zh) 2016-11-07 2018-07-01 德商拜耳廠股份有限公司 用於控制動物害蟲的經取代磺醯胺類

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718638A1 (de) * 1987-06-04 1988-12-22 Thomae Gmbh Dr K Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
GB2305665A (en) * 1995-09-26 1997-04-16 Merck & Co Inc Selective ß3 agonists for the treatment of diabetes aand obesity
EP1326861A1 (en) * 2000-10-20 2003-07-16 Pfizer Products Inc. Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
AU2002952839A0 (en) * 2002-11-21 2002-12-05 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
JP4618250B2 (ja) * 2003-12-23 2011-01-26 アステラス製薬株式会社 アミノアルコール誘導体

Similar Documents

Publication Publication Date Title
JP2005530852A5 (enExample)
RU2005101876A (ru) Производные аминоспиртов
RU2005100836A (ru) Производные пептидов, содержащие тиазепиновую группу, для лечения гиперлипемических состояний
JP2007533722A5 (enExample)
JP2013533228A5 (enExample)
RU2005123802A (ru) Производные адамантана, способы их получения и содержащие их фармацевтические композиции
JP2007510619A5 (enExample)
BR0214199A (pt) Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
JP2002520316A5 (enExample)
JP2005511697A5 (enExample)
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
WO1996018606A1 (en) Novel 1,3-dialkylurea derivatives
JP2005536503A5 (enExample)
JP2013522368A5 (enExample)
RU95106675A (ru) 3-индолилпиперидины, способ их получения, фармацевтическая композиция и способ ее получения
JP2003503449A5 (enExample)
JP2020505354A5 (enExample)
JP2004525178A5 (enExample)
JP2008511597A5 (enExample)
JP2005516898A5 (enExample)
CA2502293A1 (en) Ship 1 modulators
JP2004538278A5 (enExample)
RU2004107847A (ru) Изоксазолпиридиноны и их применение в лечении болезни паркинсона
CA2514114A1 (en) Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
JP2007516211A5 (enExample)